Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate
Fig 6
Representative leg muscle histopathologic lesions in A129 mice 14 days after infection with 104 PFU of the 181/clone25 or CHIKV/IRES vaccine candidate strains or PBS delivered in the footpad.
Green arrows indicate cellular infiltrate and moderate myositis.